Cas:102996-33-8 5-chloro-1-(3-chlorophenyl)pyrazole-4-carbonitrile manufacturer & supplier

Chemical Name:5-chloro-1-(3-chlorophenyl)pyrazole-4-carbonitrile

CAS.NO:102996-33-8

Synonyms:5-CHLORO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBONITRILE;1H-Pyrazole-4-carbonitrile,5-chloro-1-(3-chlorophenyl)

Molecular Formula:C₁₀H₅Cl₂N₃

Molecular Weight:238.07300

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:400.2ºC at 760 mmHg

Density:1.42 g/cm3

Index of Refraction:

PSA:41.61000

Exact Mass:236.98600

LogP:3.05078

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-CHLORO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBONITRILE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrazole-4-carbonitrile,5-chloro-1-(3-chlorophenyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazole-4-carbonitrile,5-chloro-1-(3-chlorophenyl) Use and application,1H-Pyrazole-4-carbonitrile,5-chloro-1-(3-chlorophenyl) technical grade,usp/ep/jp grade.

Related News: The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 5-chloro-1-(3-chlorophenyl)pyrazole-4-carbonitrile manufacturer China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 5-chloro-1-(3-chlorophenyl)pyrazole-4-carbonitrile supplier The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 5-chloro-1-(3-chlorophenyl)pyrazole-4-carbonitrile vendor The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 5-chloro-1-(3-chlorophenyl)pyrazole-4-carbonitrile factory In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.